CDKN2A and neoplasm: On targeted deep sequencing, mutations in the S2 tumor involved TP53 (chr17: 7577157, T→A splice site mutation), while mutations in the S3 tumor involved NF1, CDKN2A and TP53 (chr17: 7578556, T→C splice site mutation) (Table 2 and Figure 1).